Results 151 to 160 of about 18,317 (191)

The Application of Iron Nanoparticles Green-Synthesized by <i>Coptis chinensis</i> Leaf Aqueous Extract in Reducing the TNF-α and IL1-β Inflammatory Cytokines in the Rat Periodontal Model. [PDF]

Food Sci Nutr
Wu J, Gao X, Li R.
europepmc   +1 more source

Redox-sensitive GPCR signaling drives Gq-dependent Ca²⁺ mobilization and cytokine production in human bronchial epithelial cells. [PDF]

Am J Physiol Cell Physiol
Lapiro J, Srisomboon Y, Law K, O'Grady SM.   +3 more
europepmc   +1 more source

Neonatal CD19⁺B220^lo cells sense microbiota via TLR2/4 activation driving proliferation and differentiation. [PDF]

Front Immunol
Ruiz-Sánchez C, Cortegano I, Rodríguez M, Sanchez-Tarjuelo R, Arrabal A, Prado MC, Alia M, Jiménez MP, Lopez Molina VM, Monzón S, López-Alonso V, de Andrés B, Gaspar ML.   +12 more
europepmc   +1 more source

(Ultra-)inflammation or adaptation? Comparison of different ultramarathon distances and their effect on the immune system. [PDF]

Front Immunol
Bizjak DA, John L, Munk M, Bizjak R, Witzel J, Siebers C, Schulz SVW, Engler H, Siebers M, Kirsten J, Grau M.   +10 more
europepmc   +1 more source

Pathogenic TET2 Variants and Autoinflammatory Manifestations in Myeloid Hematologic Malignancies: Case Report and Literature Review. [PDF]

Eur J Rheumatol
Porto Fuentes Ó, De Paz Arias R, Álvarez Troncoso J.   +2 more
europepmc   +1 more source

Inflammatory transcriptomic signatures in a human cellular NMOSD model reveal upregulation of NF-κB and IL6 pathways. [PDF]

Sci Rep
Brandl S, Yu Q, Hagenbuchner J, Endmayr V, Höftberger R, Bradl M, Reindl M.   +6 more
europepmc   +1 more source

Altered Promoter Methylation of PDK4, IL1 B, IL6, and TNF After Roux-En Y Gastric Bypass

Surgery for Obesity and Related Diseases, 2014
Early benefits of Roux-en Y gastric bypass (RYGB) are partly mediated by the caloric restriction that patients undergo before and acutely after the procedure. Altered DNA methylation occurs in metabolic diseases including obesity, as well as in skeletal, muscle eight months after RYGB.
Juleen Zierath, Romain Barrés, Erik Näslund   +2 more
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

Targeting Tumor–Stromal IL6/STAT3 Signaling Through IL1 Receptor Inhibition in Pancreatic Cancer

Molecular Cancer Therapeutics, 2021
Abstract A hallmark of pancreatic ductal adenocarcinoma (PDAC) is the presence of a dense, desmoplastic stroma and the consequent altered interactions between cancer cells and their surrounding tumor microenvironment (TME) that promote disease progression, metastasis, and chemoresistance.
Austin R Dosch, Yuguang J Ban
exaly   +3 more sources

Determination of IL6, IL1, and IL4 in the Plasma of Patients With Multiple Myeloma

Leukemia and Lymphoma, 1994
Interleukin 6 (IL6) plasma levels were measured in 63 patients with multiple myeloma and 8 individuals with benign monoclonal gammopathy. 15 of these 71 samples showed by an enzyme linked immunosorbent assay (ELISA) detectable levels that ranged from 5 to 107 pg of IL6/ml.
N Jamal, M D Minden, D E Bergsagel
exaly   +3 more sources

Adult Human Vascular Endothelial Cells Express the IL6 Gene Differentially in Response to LPS or IL1

Cellular Immunology, 1989
We investigated the regulation of IL6 biological activity, de novo synthesis, and mRNA levels in adult vascular endothelial cells (EC) by bacterial endotoxin or inflammatory cytokines. Cells incubated without stimulus released scant IL6 activity. IFN gamma, IL2, or PDGF did not augment IL6 release from EC.
Peter Libby, Harald Loppnow
exaly   +3 more sources